Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Shock ; 38(4): 387-94, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22777118

ABSTRACT

We have previously demonstrated survival benefit to induced hypothermia in a porcine model of controlled hemorrhagic shock simulating an associated delay to definitive care. In the current study, we wished to evaluate the effects of environmental hypothermia in a porcine model of hemorrhagic shock with the addition of polytrauma. Sixteen pigs were randomized to normothermic (39°C, n = 7) or hypothermic (34°C, n = 9) groups. The model included instrumentation, chest injury (captive bolt device), hemorrhage to systolic blood pressure (SBP) of ∼50 mmHg, and crush liver injury. Animals received limited fluid resuscitation for a 1-h period with goal SBP of greater than 80 mmHg and ice packs or warming blankets to achieve goal temperatures, followed by full resuscitation with goal SBP of greater than 90 mmHg, adequate urine output, and hemoglobin by protocol for 20 h. Survivors were observed for an additional 24 h with end points including mortality, markers of organ injury, and neurologic function. There were no differences in survival between the groups (mortality = 1/9, hypothermia group vs. 2/7, normothermia group, P = 0.39). Markers of organ injury were elevated in the hypothermia group at 24 h after injury but were identical between groups at the end of the experimental protocol (48 h after injury). There were no noted differences in neurologic function between the two groups. Environmental hypothermia in a model of polytrauma and hemorrhagic shock was not associated with worse outcomes.


Subject(s)
Hypothermia/physiopathology , Multiple Trauma/physiopathology , Shock, Hemorrhagic/physiopathology , Animals , Disease Models, Animal , Hypothermia/pathology , Hypothermia/therapy , Multiple Trauma/pathology , Multiple Trauma/therapy , Resuscitation , Shock, Hemorrhagic/pathology , Shock, Hemorrhagic/therapy , Swine , Time Factors
2.
Resuscitation ; 83(2): 253-8, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21864484

ABSTRACT

INTRODUCTION: The neuroprotective ketone ß-hydroxybutyrate (BHB) and the antioxidant melatonin have been found at elevated levels in hibernating mammals. Previous studies in rat models of hemorrhagic shock have suggested a benefit. We compared infusion of 4M BHB and 43 mM melatonin (BHB/M) to 4M sodium chloride and 20% DMSO (control solution) to evaluate for potential benefits in porcine hemorrhagic shock. METHODS: Hemorrhagic shock was induced to obtain systolic blood pressures <50 mmHg for 60 min. Pigs were treated with a bolus of either BHB/M (n=9) or control solution (n=8) followed by 4-h infusion of the either BHB/M or control solution. All animals were then resuscitated for 20 h after shock. Physiological data were continually recorded, and blood samples were taken at intervals throughout the experiment. Serum samples were analyzed via high resolution NMR for metabolomic response. RESULTS: BHB/M treatment significantly increased 24-h survival time when compared to treatment with control solution (100% versus 62%; p=0.050), with a trend toward decreased volume of resuscitative fluid administered to animals receiving BHB/M. BHB/M-treated animals had lower base deficit and higher oxygen consumption when compared to animals receiving control solution. Serum metabolite profiles revealed increases in ß-hydroxybutyrate (BHB), succinate, 2-oxovalerate and adipate with BHB/M treatment as compared with animals treated with control infusion. CONCLUSION: Infusion of BHB/M conferred a survival benefit over infusion of control solution in hemorrhagic shock. BHB and its products of metabolism are identified in serum of animals subjected to shock and treated with BHB/M. Further preclinical studies are needed to clarify the mechanisms of action of this promising treatment strategy.


Subject(s)
3-Hydroxybutyric Acid/therapeutic use , Melatonin/therapeutic use , Resuscitation/methods , Shock, Hemorrhagic/drug therapy , Shock, Hemorrhagic/mortality , Animals , Antioxidants/therapeutic use , Disease Models, Animal , Drug Therapy, Combination , Male , Swine , Treatment Outcome
3.
Science ; 305(5692): 1966-8, 2004 Sep 24.
Article in English | MEDLINE | ID: mdl-15448271

ABSTRACT

We present the genomic sequence of Legionella pneumophila, the bacterial agent of Legionnaires' disease, a potentially fatal pneumonia acquired from aerosolized contaminated fresh water. The genome includes a 45-kilobase pair element that can exist in chromosomal and episomal forms, selective expansions of important gene families, genes for unexpected metabolic pathways, and previously unknown candidate virulence determinants. We highlight the genes that may account for Legionella's ability to survive in protozoa, mammalian macrophages, and inhospitable environmental niches and that may define new therapeutic targets.


Subject(s)
Genome, Bacterial , Legionella pneumophila/genetics , DNA, Bacterial , Gene Transfer, Horizontal , Legionella pneumophila/pathogenicity , Legionella pneumophila/physiology , Plasmids
SELECTION OF CITATIONS
SEARCH DETAIL
...